News

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.
Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his ...
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...
Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.
One of my frustrations as a pulmonary fibrosis patient is finding solid information about what to expect as my PF progresses. I’ve asked several doctors what to expect during the end stage of PF, but ...
A Phase 3 clinical trial testing Boehringer Ingelheim ’s oral investigational treatment nerandomilast in people with idiopathic pulmonary fibrosis (IPF) has met its primary goal of demonstrating the ...
Pulmonary rehabilitation is an education- and exercise-driven program that helps improve lung health and function in people with chronic lung diseases such as pulmonary fibrosis. The program is ...
Gratitude and suffering are both realities when discussing quality of life after lung transplant, columnist Christie Patient writes.
A study found 10 IPF patients given EGCG, a green tea antioxidant, for 14 days had normal levels of pro-fibrotic proteins in lung tissue.
There is no cure for pulmonary fibrosis (PF), but many therapies are in the pipeline that may be able to slow disease progression, manage symptoms, and improve quality of life for patients. Some of ...